Calithera Biosciences, Inc
CALA
CALA was delisted on the 1st of February, 2023.
76 hedge funds and large institutions have $99M invested in Calithera Biosciences, Inc in 2021 Q2 according to their latest regulatory filings, with 14 funds opening new positions, 22 increasing their positions, 29 reducing their positions, and 38 closing their positions.
568% more call options, than puts
Call options by funds: $1.14M | Put options by funds: $171K
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
22% less capital invested
Capital invested by funds: $127M → $99M (-$28.3M)
24% less funds holding
Funds holding: 100 → 76 (-24)
24% less repeat investments, than reductions
Existing positions increased: 22 | Existing positions reduced: 29
63% less first-time investments, than exits
New positions opened: 14 | Existing positions closed: 38
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BI
BVF Inc
San Francisco,
California
|
+$3.81M |
| 2 |
Morgan Stanley
New York
|
+$2.16M |
| 3 |
Millennium Management
New York
|
+$2.14M |
| 4 |
Assenagon Asset Management
Senningerberg,
Luxembourg
|
+$771K |
| 5 |
E
Ergoteles
New York
|
+$661K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BlackRock
New York
|
-$8.08M |
| 2 |
ACM
Altium Capital Management
New York
|
-$2.07M |
| 3 |
State Street
Boston,
Massachusetts
|
-$1.91M |
| 4 |
SI
Sofinnova Investments
Menlo Park,
California
|
-$1.83M |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
-$1.68M |
CALA Hedge Fund Activity: Q2 2021 in Review
76 of the 5,767 institutional investors tracked by Wall St. Rank reported a position in Calithera Biosciences, Inc (CALA) for Q2 2021, worth a combined $99M — down 22% from $127M a quarter earlier.
Sellers outnumbered buyers: 38 funds closed out of CALA and 14 opened new positions — a net loss of 24 holders — while 29 trimmed existing stakes and 22 added.
The largest buyer was BVF Inc, adding an estimated $3.81M. The largest seller was BlackRock, cutting an estimated $8.08M.
- 76 institutional investors held Calithera Biosciences, Inc (CALA) as of Q2 2021, down from 100 in Q1 2021.
- Funds reported $99M of Calithera Biosciences, Inc stock for Q2 2021, down 22% quarter-over-quarter.
- 14 funds opened new Calithera Biosciences, Inc positions in Q2 2021 and 38 closed out, a net change of -24 holders.
- The largest Calithera Biosciences, Inc buyer in Q2 2021 was BVF Inc, an estimated $3.81M added.
- The largest Calithera Biosciences, Inc seller in Q2 2021 was BlackRock, an estimated $8.08M sold.
Based on aggregated 13F filings for Q2 2021.